122 related articles for article (PubMed ID: 15473012)
1. A liquid chromatography-mass spectrometry method for the quantification of both etoricoxib and valdecoxib in human plasma.
Werner U; Werner D; Hinz B; Lambrecht C; Brune K
Biomed Chromatogr; 2005 Mar; 19(2):113-8. PubMed ID: 15473012
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous quantitation of etoricoxib, salicylic acid, valdecoxib, ketoprofen, nimesulide and celecoxib in plasma by high-performance liquid chromatography with UV detection.
Pavan Kumar VV; Vinu MC; Ramani AV; Mullangi R; Srinivas NR
Biomed Chromatogr; 2006 Jan; 20(1):125-32. PubMed ID: 16013036
[TBL] [Abstract][Full Text] [Related]
3. Determination of etoricoxib in human plasma by liquid chromatography-tandem mass spectrometry with electrospray ionisation.
Bräutigam L; Nefflen JU; Geisslinger G
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 May; 788(2):309-15. PubMed ID: 12705971
[TBL] [Abstract][Full Text] [Related]
4. Selective and rapid liquid chromatography-mass spectrometry method for the quantification of rofecoxib in pharmacokinetic studies with humans.
Werner U; Werner D; Mundkowski R; Gillich M; Brune K
J Chromatogr B Biomed Sci Appl; 2001 Aug; 760(1):83-90. PubMed ID: 11522069
[TBL] [Abstract][Full Text] [Related]
5. Validated liquid chromatographic ultraviolet method for the quantitation of Etoricoxib in human plasma using liquid-liquid extraction.
Ramakrishna NV; Vishwottam KN; Wishu S; Koteshwara M
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):215-21. PubMed ID: 15664353
[TBL] [Abstract][Full Text] [Related]
6. Determination of parecoxib and valdecoxib in rat plasma by UPLC-MS/MS and its application to pharmacokinetics studies.
Chen M; Sun W; Wang Z; Huang C; Hu G; Chen Y; Wang L
BMC Pharmacol Toxicol; 2020 Apr; 21(1):27. PubMed ID: 32264977
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the pharmacokinetics of celecoxib by liquid chromatography-mass spectrometry.
Werner U; Werner D; Pahl A; Mundkowski R; Gillich M; Brune K
Biomed Chromatogr; 2002 Feb; 16(1):56-60. PubMed ID: 11816012
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of parecoxib and its main metabolites valdecoxib and hydroxylated valdecoxib in mouse plasma with a sensitive LC-MS/MS method to elucidate the decreased drug metabolism of tumor bearing mice.
Jin X; Zhou F; Liu Y; Cheng C; Yao L; Jia Y; Wang G; Zhang J
J Pharm Biomed Anal; 2018 Sep; 158():1-7. PubMed ID: 29843006
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of Valdecoxib in human plasma by high-performance liquid chromatography with ultraviolet absorbance detection using liquid-liquid extraction.
Ramakrishna NV; Vishwottam KN; Wishu S; Koteshwara M
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 802(2):271-5. PubMed ID: 15018787
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of an automated SPE-LC-MS/MS assay for valdecoxib and its hydroxylated metabolite in human plasma.
Zhang JY; Fast DM; Breau AP
J Pharm Biomed Anal; 2003 Sep; 33(1):61-72. PubMed ID: 12946532
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of unlabeled and carbon-13-labeled etoricoxib, a new cyclooxygenase-2 inhibitor, in human plasma using HPLC-MS/MS.
Rose MJ; Agrawal N; Woolf EJ; Matuszewski BK
J Pharm Sci; 2002 Feb; 91(2):405-16. PubMed ID: 11835200
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous detection and quantification of parecoxib and valdecoxib in canine plasma by HPLC with spectrofluorimetric detection: development and validation of a new methodology.
Saccomanni G; Giorgi M; Del Carlo S; Manera C; Saba A; Macchia M
Anal Bioanal Chem; 2011 Sep; 401(5):1677-84. PubMed ID: 21769548
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous Determination of Parecoxib and Its Metabolite Valdecoxib Concentrations in Beagle Plasma by UPLC-MS/MS and Application for Pharmacokinetics Study.
Li SL; Zhu YL; Zhu CY; Li SB; Li ZH; Qiu XJ
Drug Des Devel Ther; 2020; 14():1117-1125. PubMed ID: 32214797
[TBL] [Abstract][Full Text] [Related]
14. Determination of valdecoxib in serum using a HPLC-diode array detector and its application in a pharmacokinetic study.
Keshetty S; Venisetty RK; Molmoori V; Ciddi V
Pharmazie; 2006 Mar; 61(3):245-6. PubMed ID: 16599270
[TBL] [Abstract][Full Text] [Related]
15. The biochemical selectivity of novel COX-2 inhibitors in whole blood assays of COX-isozyme activity.
Tacconelli S; Capone ML; Sciulli MG; Ricciotti E; Patrignani P
Curr Med Res Opin; 2002; 18(8):503-11. PubMed ID: 12564662
[TBL] [Abstract][Full Text] [Related]
16. Determination of rofecoxib (MK-0966), a cyclooxygenase-2 inhibitor, in human plasma by high-performance liquid chromatography with tandem mass spectrometric detection.
Chavez-Eng CM; Constanzer ML; Matuszewski BK
J Chromatogr B Biomed Sci Appl; 2000 Oct; 748(1):31-9. PubMed ID: 11092584
[TBL] [Abstract][Full Text] [Related]
17. Disposition of a specific cyclooxygenase-2 inhibitor, valdecoxib, in human.
Yuan JJ; Yang DC; Zhang JY; Bible R; Karim A; Findlay JW
Drug Metab Dispos; 2002 Sep; 30(9):1013-21. PubMed ID: 12167567
[TBL] [Abstract][Full Text] [Related]
18. Validation of liquid chromatography and liquid chromatography/tandem mass spectrometry methods for the determination of etoricoxib in pharmaceutical formulations.
Brum L; Fronza M; Ceni DC; Barth T; Dalmora SL
J AOAC Int; 2006; 89(5):1268-75. PubMed ID: 17042175
[TBL] [Abstract][Full Text] [Related]
19. An effective dose of valdecoxib in experimental mouse models of pain.
Guo CX; Irwin MG; Cheung KM; Chan D
Methods Find Exp Clin Pharmacol; 2007; 29(6):383-8. PubMed ID: 17922065
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of rofecoxib and celecoxib in human plasma by high-performance liquid chromatography.
Hamama AK; Ray J; Day RO; Brien JA
J Chromatogr Sci; 2005 Aug; 43(7):351-4. PubMed ID: 16176646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
